Chemours (CC) EBT (2014 - 2026)

Chemours' EBT history runs 13 years deep, the most recent figure standing at -$22.0 million for Q1 2026.

• On a quarterly basis, EBT changed N/A year-over-year to -$22.0 million in Q1 2026; TTM through Mar 2026 was -$299.0 million, a 886.84% decrease from a year earlier, with the FY2025 full-year figure at -$453.0 million, down 107.8% from the prior year.
• EBT rose to -$22.0 million in Q1 2026 per CC's latest filing, from -$67.0 million in the prior quarter.
• Across five years, EBT topped out at $299.0 million in Q3 2022 and bottomed at -$433.0 million in Q2 2023.
• The 5-year median for EBT is $7.0 million (2023), against an average of $14.5 million.
• Across the five-year window, EBT jumped 425.0% in 2022 and plunged 6800.0% in 2025, its largest moves.
• Year by year, EBT stood at -$69.0 million in 2022, then declined by 2.9% to -$71.0 million in 2023, then surged by 101.41% to $1.0 million in 2024, then plunged by 6800.0% to -$67.0 million in 2025, then jumped by 67.16% to -$22.0 million in 2026.
• Per Business Quant, the three latest CC EBT figures stand at -$22.0 million (Q1 2026), -$67.0 million (Q4 2025), and $38.0 million (Q3 2025).